KDOQI clinical practice guideline for vascular access: 2019 update
CE Lok, TS Huber, T Lee, S Shenoy, AS Yevzlin… - American Journal of …, 2020 - Elsevier
Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …
[PDF][PDF] Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit
SR Dariushnia, TG Walker, JE Silberzweig… - J Vasc Interv …, 2016 - academia.edu
When the evidence of literature is weak, conflicting, or contradictory, consensus for the
parameter is reached by a minimum of 12 Standards of Practice Committee members using …
parameter is reached by a minimum of 12 Standards of Practice Committee members using …
[HTML][HTML] Choosing the right treatment for the right lesion, part I: a narrative review of the role of plain balloon angioplasty in dialysis access maintenance
DM DePietro, SO Trerotola - Cardiovascular Diagnosis and …, 2023 - ncbi.nlm.nih.gov
Methods An electronic search was performed on PubMed and EMBASE to identify relevant
articles from 1980 to 2022. The highest available level of evidence regarding stenosis …
articles from 1980 to 2022. The highest available level of evidence regarding stenosis …
Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis …
G Maleux, W Vander Mijnsbrugge… - Journal of Vascular and …, 2018 - Elsevier
Purpose To investigate the potential added value of paclitaxel-coated balloon (PCB)
angioplasty to reduce fistula dysfunction related to recurrent stenoses in patients undergoing …
angioplasty to reduce fistula dysfunction related to recurrent stenoses in patients undergoing …
A survival guide for endovascular declotting in dialysis access: procedures, devices, and a statistical analysis of 3,000 cases
PM Kitrou, K Katsanos, P Papadimatos… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Thrombosis is the most important access-related complication. Several
declotting procedures have been suggested falling mainly into two categories; thrombolysis …
declotting procedures have been suggested falling mainly into two categories; thrombolysis …
Cutting balloons, covered stents and paclitaxel-coated balloons for the treatment of dysfunctional dialysis access
Introduction: Percutaneous transcatheter balloon angioplasty has evolved to the current
mainstay treatment for salvage of dysfunctional dialysis access. Nonetheless, it is frequently …
mainstay treatment for salvage of dysfunctional dialysis access. Nonetheless, it is frequently …
[HTML][HTML] Combined treatment of dysfunctional dialysis access with cutting balloon and paclitaxel-coated balloon in real world
T Böhme, E Noory, U Beschorner, B Jacques… - Vasa, 2023 - econtent.hogrefe.com
Background: Dysfunction in arteriovenous (AV) access is a common reason for subsequent
intervention. To evaluate the results of endovascular treatment of AV access lesions using …
intervention. To evaluate the results of endovascular treatment of AV access lesions using …
[HTML][HTML] Network meta-analysis of trials comparing first line endovascular treatments for arteriovenous fistula stenosis
G Tripsianis, E Christaina, C Argyriou… - Journal of Vascular …, 2021 - Elsevier
Objective We investigated the comparative effectiveness of different endovascular
treatments for patients with failing autogenous arteriovenous fistulas (AVFs) with outflow …
treatments for patients with failing autogenous arteriovenous fistulas (AVFs) with outflow …
Recurrent stenoses in arteriovenous fistula (AVF) for dialysis access: cuttIng ballooN angioplaSTy combined wITh paclitaxel drUg-coaTed balloon angioplasty, an …
Z Tan, SXJM Chan, K Da Zhuang, T Urlings… - CardioVascular and …, 2022 - Springer
Purpose To study the safety and efficacy of cutting balloon angioplasty (CBA) followed by
paclitaxel drug-coated balloon (PCB) angioplasty for recurrent venous lesions in …
paclitaxel drug-coated balloon (PCB) angioplasty for recurrent venous lesions in …
Comparing the 12-month patency of low-versus high-pressure dilation in failing arteriovenous fistulae: a prospective multicenter trial (YOROI study)
K Wakamoto, S Doi, A Nakashima… - The Journal of …, 2018 - journals.sagepub.com
Purpose: This study was performed to investigate the effect of the balloon dilation pressure
on the 12-month patency rate in patients with failed arteriovenous fistulas undergoing …
on the 12-month patency rate in patients with failed arteriovenous fistulas undergoing …